Movement Alert|Axon Enterprise, Inc. Rises 3.18% in Regular Trading, Q2 Earnings Beat and Institutional Price Target Upgrades Fuel Rebound

Market Focus
Aug 13

On August 13, Axon Enterprise, Inc. rose 3.18% in regular trading, trading at approximately $619.12 per share, with turnover of $72.22 million. The stock continued its rebound momentum driven by strong Q2 results and broad institutional bullishness.

On the earnings front, the company reported Q2 revenue of $904.4 million, up 35.3% year-over-year, beating the consensus estimate of $876.4 million. Non-GAAP EPS came in at $1.88, also exceeding the $1.84 analyst expectation. The company raised its full-year revenue growth guidance to 32%-34%, up from the prior 30%-32% range. Morgan Stanley characterized the results as \"clean,\" noting that $15.1 billion in future contracted bookings indicate a \"healthy underlying demand environment.\" The firm now projects 33% revenue growth for the current year and 34% for the following year, citing continued traction across counter-drone, international, and enterprise markets.

On the institutional side, Piper Sandler raised its price target to $724, Needham lifted its target to $750, and RBC Capital Markets maintained a $735 target, collectively reinforcing a buy consensus with a mean target of approximately $686.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10